• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类CD59的绵羊类似物:其补体抑制活性的纯化与特性分析

The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

作者信息

van den Berg C W, Harrison R A, Morgan B P

机构信息

Dept. of Medical Biochemistry, University of Wales College of Medicine, Cardiff, U.K.

出版信息

Immunology. 1993 Mar;78(3):349-57.

PMID:7682985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1421828/
Abstract

An inhibitor of the membrane attack complex of complement was isolated from the membranes of sheep erythrocytes. Fast protein liquid chromatography (FPLC) and affinity purification procedures for this sheep complement-inhibiting protein (SCIP) both yielded a pure protein with an apparent M(r) of 19,000 under reducing and non-reducing conditions. Incubation of the denatured protein with neuraminidase and Endo-F reduced the apparent M(r) to 18,000 and 15,000 respectively, while treatment with O-deglycosidase or phosphatidylinositol-specific phospholipase C (PIPLC) did not affect the apparent M(r). SCIP was detectable on erythrocytes and lymphocytes but not on platelets and could partially be removed by PIPLC treatment. Deglycosylation of the pure protein markedly reduced and PIPLC treatment abolished its activity. A monoclonal antibody (mAb) raised against sheep complement-inhibiting protein (SCIP) enhanced the susceptibility of sheep erythrocytes to lysis by homologous complement. SCIP inhibited complement after the stage of C5b-7 formation. Amino-terminal protein sequence was obtained and was shown to be similar to that of human CD59. All these features suggest that SCIP is the sheep equivalent of human CD59. Human CD59 has been reported to be species selective in that it inhibits complement from relatively few species. However, SCIP efficiently inhibited lysis of guinea-pig erythrocytes by complement from a wide range of species tested indicating that it is a potent and non-selective inhibitor of the membrane attack complex of complement (MAC).

摘要

从绵羊红细胞膜中分离出一种补体膜攻击复合物抑制剂。针对这种绵羊补体抑制蛋白(SCIP)的快速蛋白质液相色谱(FPLC)和亲和纯化程序,在还原和非还原条件下均产生了一种表观分子量为19,000的纯蛋白。将变性蛋白与神经氨酸酶和内切糖苷酶F孵育后,表观分子量分别降至18,000和15,000,而用O-糖苷酶或磷脂酰肌醇特异性磷脂酶C(PIPLC)处理则不影响表观分子量。在红细胞和淋巴细胞上可检测到SCIP,但在血小板上未检测到,并且PIPLC处理可部分去除SCIP。纯蛋白的去糖基化显著降低其活性,而PIPLC处理则使其活性丧失。针对绵羊补体抑制蛋白(SCIP)产生的单克隆抗体(mAb)增强了绵羊红细胞对同源补体裂解的敏感性。SCIP在C5b-7形成阶段之后抑制补体。获得了氨基末端蛋白质序列,显示其与人CD59的序列相似。所有这些特征表明SCIP是人类CD59的绵羊等同物。据报道,人类CD59具有物种选择性,即它仅抑制少数物种的补体。然而,SCIP有效抑制了来自广泛测试物种的补体对豚鼠红细胞的裂解,表明它是补体膜攻击复合物(MAC)的一种强效且非选择性的抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb0/1421828/c5b2c76ccec4/immunology00098-0015-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb0/1421828/90eec88fdc65/immunology00098-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb0/1421828/c5b2c76ccec4/immunology00098-0015-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb0/1421828/90eec88fdc65/immunology00098-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb0/1421828/c5b2c76ccec4/immunology00098-0015-a.jpg

相似文献

1
The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.人类CD59的绵羊类似物:其补体抑制活性的纯化与特性分析
Immunology. 1993 Mar;78(3):349-57.
2
Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.从大鼠红细胞中分离并鉴定一种膜蛋白,该蛋白可抑制大鼠补体膜攻击复合物介导的细胞溶解。
Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):169-76. doi: 10.1042/bj2840169.
3
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59.曼氏血吸虫94-kD蛋白(SCIP-1)与人CD59之间的功能和抗原相似性
J Exp Med. 1994 May 1;179(5):1625-36. doi: 10.1084/jem.179.5.1625.
4
Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted.人CD59以及大鼠、绵羊和猪的类似物的补体抑制活性不受同源限制。
J Immunol. 1994 Apr 15;152(8):4095-101.
5
A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: application to pig CD59.一种通过制备型SDS-PAGE快速分离人CD59类似物的方法:应用于猪CD59
J Immunol Methods. 1995 Feb 27;179(2):223-31. doi: 10.1016/0022-1759(94)00288-8.
6
A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.一种阻断豚鼠红细胞补体调节活性的单克隆抗体以及所涉及抗原作为豚鼠衰变加速因子的特性鉴定
J Immunol. 1995 Jun 1;154(11):6103-11.
7
A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.一种来自补体蛋白C9的合成肽与CD59结合,并增强C5b-9对人红细胞的裂解作用。
J Immunol. 1994 Feb 15;152(4):1927-34.
8
Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.CD59对同源补体的抑制作用是通过与C5b-8中的C8或C5b-9中的C9结合所赋予的物种选择性识别来介导的。
J Immunol. 1991 Apr 1;146(7):2345-51.
9
The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.CD59的补体抑制活性在于其阻止C9掺入膜攻击复合物C5b-9的能力。
J Immunol. 1990 May 1;144(9):3478-83.
10
Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.从血小板膜中分离和鉴定补体抑制蛋白CD59抗原
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):409-13. doi: 10.1042/bj2820409.

引用本文的文献

1
Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.使用新型单克隆抗体对小鼠CD59类似物进行表征:组织分布及功能比较
Immunology. 2003 May;109(1):117-26. doi: 10.1046/j.1365-2567.2003.01628.x.
2
Molecular basis for a link between complement and the vascular complications of diabetes.补体与糖尿病血管并发症之间联系的分子基础。
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5450-5. doi: 10.1073/pnas.97.10.5450.
3
Production and functional characterization of a soluble recombinant form of mouse CD59.

本文引用的文献

1
Preparation of monoclonal antibodies: strategies and procedures.单克隆抗体的制备:策略与程序
Methods Enzymol. 1981;73(Pt B):3-46. doi: 10.1016/0076-6879(81)73054-4.
2
Cobra venom factor: improved method for purification and biochemical characterization.眼镜蛇毒因子:纯化及生化特性鉴定的改良方法
J Immunol Methods. 1984 Oct 12;73(1):203-20. doi: 10.1016/0022-1759(84)90045-0.
3
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.聚丙烯酰胺凝胶中蛋白质的银染:一种具有增强均匀灵敏度的改良方法。
小鼠CD59可溶性重组形式的产生及功能特性分析
Immunology. 2000 Feb;99(2):326-32. doi: 10.1046/j.1365-2567.2000.00936.x.
4
Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies.使用新型单克隆抗体对人CD59猪类似物进行体外和体内表征。
Immunology. 1998 Nov;95(3):450-9. doi: 10.1046/j.1365-2567.1998.00623.x.
5
Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function.大鼠CD59的表达:功能分析证实缺乏物种选择性,并表明功能不需要糖基化。
Immunology. 1997 Apr;90(4):640-6. doi: 10.1046/j.1365-2567.1997.00200.x.
6
Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.补体抑制糖蛋白CD59活性位点及抗体表位的突变分析
J Exp Med. 1997 Feb 3;185(3):507-16. doi: 10.1084/jem.185.3.507.
7
GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells.精浆中的糖基磷脂酰肌醇锚定补体调节蛋白。其物理状态及与外源细胞结合机制的分析
J Clin Invest. 1996 Apr 1;97(7):1675-86. doi: 10.1172/JCI118594.
8
Membrane proteins that protect against complement lysis.防止补体溶解的膜蛋白。
Springer Semin Immunopathol. 1994;15(4):369-96. doi: 10.1007/BF01837366.
9
Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector.利用杆状病毒载体在昆虫细胞中表达糖基磷脂酰肌醇连接的补体抑制蛋白CD59抗原。
Biochem J. 1993 Nov 1;295 ( Pt 3)(Pt 3):889-96. doi: 10.1042/bj2950889.
10
Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.大鼠人CD59类似物的分子克隆:与人CD59的结构比较及一个假定活性位点的鉴定
Biochem J. 1994 Dec 1;304 ( Pt 2)(Pt 2):595-601. doi: 10.1042/bj3040595.
Anal Biochem. 1981 Nov 1;117(2):307-10. doi: 10.1016/0003-2697(81)90783-1.
4
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
5
A novel glycoprotein expressed on sheep T and B lymphocytes is involved in a T cell activation pathway.一种在绵羊T淋巴细胞和B淋巴细胞上表达的新型糖蛋白参与了T细胞激活途径。
J Immunol. 1988 May 1;140(9):2869-75.
6
Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex.补体对血小板的调节控制。C5b-9复合物的膜抑制剂对血小板促凝反应的调节作用。
J Biol Chem. 1989 Nov 15;264(32):19228-35.
7
A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.一种能够抑制同源补体介导的膜攻击的新型膜糖蛋白。
Int Immunol. 1989;1(2):205-8. doi: 10.1093/intimm/1.2.205.
8
Evidence that the B5 molecule on sheep lymphocytes is a homologue of mouse Ly 6 and human CD59.绵羊淋巴细胞上的B5分子是小鼠Ly 6和人类CD59同源物的证据。
Immunology. 1989 Dec;68(4):580-2.
9
Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.能够通过同源补体引起神经氨酸酶处理的人红细胞溶血的单克隆抗体。
J Immunol. 1989 Oct 1;143(7):2262-6.
10
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.CD59是一种在人类淋巴细胞中表达的类LY-6蛋白,可调节补体膜攻击复合物对同源细胞的作用。
J Exp Med. 1989 Sep 1;170(3):637-54. doi: 10.1084/jem.170.3.637.